No Data
No Data
No Data
Jinghua Pharmaceutical (002349.SZ): The company currently has no synthetic biological layout
On May 7, Gelonghui Pharmaceutical (002349.SZ) said on the investor interactive platform that the company currently has no synthetic biological layout.
Jinghua Pharmaceutical (002349.SZ): Net profit of 71.081 million yuan in the first quarter decreased by 18.92% year-on-year
On April 29, Ge Longhui Pharmaceutical (002349.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 367 million yuan, down 11.82% year on year; net profit attributable to shareholders of listed companies was 71.0801 million yuan, down 18.92% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 658.11,500 yuan, down 23.09% year on year; basic earnings per share were 0.0873 yuan.
Jinghua Pharmaceutical (002349.SZ): 2023 net profit of 248 million yuan, plans to distribute 10 0.92 yuan
Gelonghui, April 18 | Jinghua Pharmaceutical (002349.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 1,512 billion yuan, a year-on-year decrease of 3.90%; net profit attributable to shareholders of listed companies was 248 million yuan, up 16.71% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 237 million yuan, an increase of 35.00% year on year; basic income per share was 0.3042 yuan; it plans to distribute a cash dividend of 0.92 yuan (tax included) to all shareholders for every 10 shares.
Jinghua Pharmaceutical's Unit Shuts Down Amid Water Pollution Probe
Jinghua Pharmaceutical Group's (SHE:002349) unit, Ningxia Senxuan Pharmaceutical, suspended operations amid an investigation over water pollution violations, according to the company's disclosure on t
Express News | Jinghua Pharmaceutical: Sun Company Ningxia Senxuan Pharmaceutical was ordered to shut down and rectify
Jinghua Pharmaceutical (002349.SZ): The subsidiary Luhua Senxuan Dioxane's dioxane pentacyclic products are currently mainly used in the field of copolymer formaldehyde
Gelonghui, April 10 | Jinghua Pharmaceutical (002349.SZ) said on the investor interactive platform that its subsidiary Luhua Senxuan's dioxy-5-ring products are currently mainly used in the field of copolymer formaldehyde; in the field of lithium batteries, they are mainly used as primary battery electrolytes for lithium iron phosphate routes, and are currently mainly supplied to companies with related business in this field.
No Data